Kalle Kristian Åström

Veraventure Oy is a venture capital investment firm based in Kuopio, Finland. Established in 2003, they are a wholly-owned subsidiary of Finnvera Oy. Veraventure is responsible for the management and development of the parent firm's investments linked to regional funds. Finnvera is a specialized financing firm, owned and operated by the Finnish Government and supervised by the Ministry of Trade and Industry. Veraventure specializes in complementing regional markets in equity financing. They have a particular focus on early-stage financing as well as providing capital related to generational changes and for small and mid-size firms. They are the investment manager of the Seed Fund Vera. The firm also has offices in Oulu and Helsinki, Finland.

MediSapiens Oy provides solutions for bioinformatics analysis. It offers software and products for biological research. The firm creates customized bioinformatics software solutions to organizations; ranging from data management system, to full sample and data processing system, to an animal deoxyribonucleic acid testing service. Its products include Biond Explorer; Research Integrator; IST Online; Target Scout; and Fusion Scout. The company was founded by Sami Kalevi Kilpinen, Olli-Pekka Kallioniemi, and Tommi Pisto in 2009 and is headquartered in Helsinki, Finland.

Nanocomp Oy Ltd. designs and manufactures micro- and nanophotonics solutions. It develops thin foil optics. The firm offers service from design to tooling and mass production of micro- and nanoscale surface structures. It products and services is use for displays; three-dimensional sensing/gesture recognition; laser measuring; wearable devices; and healthcare application. The company was founded by Veli-Pekka Leppänen in 1997 and is headquartered in Lehmo, Finland.

Finnvera Oyj is a financing company that provides financing for the start-up, growth, and internationalization of enterprises and for protection against export risks. Its products include loans, domestic guarantees, export credit guarantees, venture capital investments, export credits, and interest equalization. The company was founded on July 9, 1998 and is headquartered in Kuopio, Finland.

Plexpress offers high-content gene expression analysis for cell biology research, enabling higher throughput and providing more information than competitors' products. Plexpress analysis service is a cost and time efficient solution for large screens in preclinical drug discovery studies, safety assays and yeast studies. Plexpress was established as a spinoff from the Finnish Technology Research Center VTT in 2007. Including R&D at VTT, the company's TRAC technology has been developed continuously for nearly 10 years and it has been documented in over 15 publications. The technology was originally developed for demanding bioprocess applications, which required a very robust solution for gene expression analysis. The principal developers of the technology, Hans Soderlund and Jari Rautio, are still closely involved with the company as Chairman of the Scientific Advisory Board and VP of R&D, respectively. Since starting operations in 2008, the company has carried out projects using the TRAC technology in the fields of pharmaceutical development and academic research.